HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

INSILICO

40.620

-3.580-8.10%

Volume:18.78M

Turnover:777.40M

Market Cap:23.64B

PE:-9.07

High:44.500

Open:43.560

Low:40.260

Close:44.200

52wk High:80.900

52wk Low:29.980

Shares:582.00M

HK Float Shares:582.00M

Volume Ratio:1.02

T/O Rate:3.23%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-4.480

ROE:--

ROA:-11.83%

PB:6.67

PE(LYR):-9.07

PS:53.61

Loading ...

Overview Company News Filings

InSilico Medicine Invests $105 Million in Wealth Management Products

MT Newswires Live

BRIEF-Insilico Medicine Cayman Topco, Unit Subscribe For Wealth Management Products

INSILICO Announces Subscription of Financial Products

Insilico Medicine places USD105.00 million in treasury products, cash position rises to USD596.00 million

Bulletin Express

Insilico Medicine Cayman Topco - Co and Unit Subscribes for Wealth Management Products on April 29, 2026

THOMSON REUTERS

Insilico Medicine Cayman Topco - Subscribes to Cmb International USD Money Market Fund for USD50 Mln

THOMSON REUTERS

Stock Track | Insilico Medicine Soars 5.14% Intraday on China IND Approval for Rentosertib IPF Therapy

BRIEF-Insilico Medicine Cayman Topco Receives Center For Drug Evaluation's IND Approval For Inhaled Rentosertib

Insilico Medicine Cayman Topco - Receives Center for Drug Evaluation of Nmpa's Ind Approval for Inhaled Rentosertib

THOMSON REUTERS

Insilico Medicine says China CDE approves IND for Rentosertib inhalation solution

INSILICO shifts to fully electronic delivery of corporate communications under HKEX Rule 2.07A

Bulletin Express

英妙智能2025年报：营收下降与亏损扩大，AI新药研发平台获多方关注，资本结构显著改善

Bulletin Express

InSilico Implements Electronic-Only Distribution of Corporate Communications to Shareholders

Bulletin Express

INSILICO Sets 2 June 2026 Virtual AGM; Eyes 10% Buy-Back Mandate and 20% Issuance Capacity

Bulletin Express

INSILICO to Seek Shareholders’ Nod for 10 % Buyback, 20 % Issuance Mandates and Board Re-election at 2 June Virtual AGM

Bulletin Express

InSilico Medicine Schedules 2 June 2026 Virtual AGM; Director Re-elections, 10% Buyback and 20% Issuance Mandates Proposed

Bulletin Express

Insilico Medicine Cayman Topco announces annual general meeting

Stock Track | Insilico Medicine Plummets 5.16% Intraday as Profit-Taking Persists Amid Strong Sector Performance

Stock Track | Insilico Medicine Plummets 5.65% Intraday as Profit-Taking Follows AI Drug Discovery Rally

Insilico Medicine Nominates AI-Developed Brain Cancer Drug Candidate

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/03696/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"03696","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"03696\",,,,,undefined,":{"symbol":"03696","market":"HK","secType":"STK","nameCN":"INSILICO","latestPrice":40.62,"timestamp":1787299688006,"preClose":44.2,"halted":0,"volume":18778893,"delay":0,"changeRate":-0.08099547511312229,"floatShares":582000000,"shares":582000000,"eps":-4.48,"marketStatus":"Not Yet Opened","change":-3.58,"latestTime":"08-21 16:08:08","open":43.56,"high":44.5,"low":40.26,"amount":777399663,"amplitude":0.095928,"askPrice":40.62,"askSize":2000,"bidPrice":40.6,"bidSize":10500,"shortable":3,"etf":0,"ttmEps":-4.707,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787535000000},"marketStatusCode":0,"adr":0,"listingDate":1767024000000,"exchange":"SEHK","adjPreClose":44.2,"openAndCloseTimeList":[[1787275800000,1787284800000],[1787288400000,1787299200000]],"volumeRatio":1.0245156720310378,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"03696\",,,,,undefined,":{"symbol":"03696","floatShares":582000000,"roa":"-11.83%","roe":"--","lyrEps":-4.48,"volumeRatio":1.0245156720310378,"shares":582000000,"dividePrice":0,"high":44.5,"amplitude":0.095928,"preClose":44.2,"low":40.26,"week52Low":29.98,"pbRate":"6.67","psRate":"53.61","week52High":80.9,"institutionHeld":0,"latestPrice":40.62,"committee":0.68,"eps":-4.48,"divideRate":0,"volume":18778893,"delay":0,"ttmEps":-4.707,"open":43.56,"prevYearClose":37.14,"prevWeekClose":40.62,"prevMonthClose":45.7,"prevQuarterClose":39.62,"fiveDayClose":44.56,"twentyDayClose":47.06,"sixtyDayClose":48.1,"earningDate":1787673600000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/03696\",params:#limit:5,,,undefined,":[{"date":"2026-08-26","symbol":"03696","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787707800000,"name":null,"time":"","dateTimestamp":1787673600000,"actualEps":null},{"date":"2026-03-30","symbol":"03696","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774834200000,"name":null,"time":"","dateTimestamp":1774800000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"03696\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"03696\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.75,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.75,"analysts":8,"updateTime":1786032000000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/03696\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"03696","date":"2026-08-21","current":-8.6297,"percent":0.853503,"low":-126.474328,"twenty":-93.349385,"median":-12.788902,"eighty":-8.725669,"high":-6.819055,"avg":-42.885428,"sd":42.328622,"marketCap":23250969240},"quantilePoints":[{"date":"2026-01-02","current":-60.518922,"twenty":-60.091977,"median":-54.070713,"eighty":-44.509914,"marketCap":20885577298},{"date":"2026-01-09","current":-75.603624,"twenty":-68.00457,"median":-60.518922,"eighty":-55.21804,"marketCap":26120865700},{"date":"2026-01-16","current":-88.730045,"twenty":-88.029114,"median":-68.708073,"eighty":-60.032461,"marketCap":30678123120},{"date":"2026-01-23","current":-103.197987,"twenty":-90.498742,"median":-83.671368,"eighty":-60.384368,"marketCap":35679909160},{"date":"2026-01-30","current":-103.586135,"twenty":-97.608242,"median":-87.528966,"eighty":-61.04227,"marketCap":35850899140},{"date":"2026-02-06","current":-102.242154,"twenty":-102.624487,"median":-88.730045,"eighty":-63.670801,"marketCap":35423424190},{"date":"2026-02-13","current":-120.862692,"twenty":-111.02361,"median":-93.674734,"eighty":-69.411577,"marketCap":41892545100},{"date":"2026-02-20","current":-120.573146,"twenty":-113.535701,"median":-95.532684,"eighty":-72.22559,"marketCap":41778551780},{"date":"2026-02-27","current":-101.790811,"twenty":-112.276672,"median":-99.165731,"eighty":-75.603624,"marketCap":35309430870},{"date":"2026-03-06","current":-91.269503,"twenty":-111.865913,"median":-96.698006,"eighty":-83.671368,"marketCap":31633146300},{"date":"2026-03-13","current":-90.695168,"twenty":-110.462075,"median":-97.855611,"eighty":-84.923636,"marketCap":31476674990},{"date":"2026-03-20","current":-90.217416,"twenty":-108.336494,"median":-95.132264,"eighty":-85.637602,"marketCap":31333988340},{"date":"2026-03-27","current":-94.081335,"twenty":-107.867915,"median":-93.382526,"eighty":-84.923636,"marketCap":32646705520},{"date":"2026-04-02","current":-11.868567,"twenty":-107.743793,"median":-93.151788,"eighty":-79.84609,"marketCap":32770014500},{"date":"2026-04-10","current":-12.877757,"twenty":-106.637664,"median":-92.691879,"eighty":-68.00457,"marketCap":35546164200},{"date":"2026-04-17","current":-12.624497,"twenty":-104.449464,"median":-91.076584,"eighty":-59.957423,"marketCap":34802041600},{"date":"2026-04-24","current":-14.676127,"twenty":-103.459526,"median":-89.747522,"eighty":-15.148699,"marketCap":40497441500},{"date":"2026-04-30","current":-13.071473,"twenty":-103.255287,"median":-88.68986,"eighty":-14.223075,"marketCap":36089946100},{"date":"2026-05-08","current":-13.340785,"twenty":-103.091175,"median":-88.574112,"eighty":-13.384736,"marketCap":36805448600},{"date":"2026-05-15","current":-10.983422,"twenty":-102.596106,"median":-86.723486,"eighty":-13.331626,"marketCap":30308685900},{"date":"2026-05-22","current":-10.451313,"twenty":-102.308283,"median":-85.637602,"eighty":-12.881328,"marketCap":28849060800},{"date":"2026-05-29","current":-8.622113,"twenty":-102.242154,"median":-83.671368,"eighty":-12.624497,"marketCap":23800475160},{"date":"2026-06-05","current":-7.875348,"twenty":-101.790811,"median":-78.255166,"eighty":-12.515704,"marketCap":21739827960},{"date":"2026-06-12","current":-7.01543,"twenty":-100.06892,"median":-65.190557,"eighty":-12.085532,"marketCap":19370083680},{"date":"2026-06-18","current":-7.947724,"twenty":-100.046598,"median":-60.518922,"eighty":-10.958896,"marketCap":21945892680},{"date":"2026-06-26","current":-7.919554,"twenty":-99.340788,"median":-54.070713,"eighty":-10.005367,"marketCap":21877204440},{"date":"2026-07-03","current":-7.743582,"twenty":-98.690073,"median":-27.191152,"eighty":-9.565807,"marketCap":21396386760},{"date":"2026-07-10","current":-8.877372,"twenty":-98.062553,"median":-14.676127,"eighty":-8.824583,"marketCap":24510253640},{"date":"2026-07-17","current":-8.953114,"twenty":-97.4013,"median":-14.167396,"eighty":-8.882012,"marketCap":24727766400},{"date":"2026-07-24","current":-9.751189,"twenty":-96.617922,"median":-13.560542,"eighty":-8.925911,"marketCap":26937238120},{"date":"2026-07-31","current":-9.466525,"twenty":-95.411086,"median":-13.340785,"eighty":-8.88656,"marketCap":26158771400},{"date":"2026-08-07","current":-9.410567,"twenty":-94.035578,"median":-13.201047,"eighty":-8.763781,"marketCap":26009946880},{"date":"2026-08-14","current":-9.225945,"twenty":-93.733176,"median":-12.895614,"eighty":-8.825762,"marketCap":25506233120},{"date":"2026-08-21","current":-8.414722,"twenty":-93.349385,"median":-12.788902,"eighty":-8.725669,"marketCap":23250969240}],"updateTime":1787504586052},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"03696\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2631357738","title":"InSilico Medicine Invests $105 Million in Wealth Management Products","url":"https://stock-news.laohu8.com/highlight/detail?id=2631357738","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631357738?lang=en_us&edition=fundamental","pubTime":"2026-04-30 10:37","pubTimestamp":1777516654,"startTime":"0","endTime":"0","summary":"InSilico Medicine  invested $105 million in wealth management products offered by CMB International and JPMorgan, according to a Hong Kong bourse filing Thursday.The AI-driven drug discovery firm invested $50 million in a money market fund managed by CMB International Asset Management with an expected 3.99% annualized rate of return; $50 million in a variable net asset value money market fund by JPMorgan Asset Management with an expected 3.85% annualized rate of return; and a further $5 million in a dual-currency deposit issued by JPMorgan Chase Bank with an expected 4.68% rate of return.The subscriptions were made with the view of \"enhancing returns on surplus cash,\" the firm said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BLSP4239.USD","BK1141","LU0640476718.USD","LU1988902786.USD","SG9999002224.SGD","IE00BKDWB100.SGD","LU0265550946.USD","IE00BYXW3230.USD","LU1551013425.SGD","LU2211815571.USD","LU1084165304.USD","BK4550","IE00BWXC8680.SGD","LU2023250843.SGD","LU0820562030.AUD","IE00BJTD4N35.SGD","LU0211331839.USD","IE00BLSP4452.SGD","LU0149725797.USD","LU0496365809.HKD","LU1162221912.USD","LU2023250330.USD","LU2552382058.USD","LU2106854487.HKD","LU0320765646.SGD","LU0787776722.HKD","LU2505996509.AUD","LU2417539215.USD","LU1244550577.SGD","JPMO","LU1496350502.SGD","BK4585","IE00BFXG1179.USD","BK4504","LU1670628061.USD","BK4516","LU2213496289.HKD","IE00BJLML261.HKD","LU2237443978.SGD","LU0267386448.USD","LU2746668974.SGD","LU2505996681.GBP","03696","IE00BN8TJ469.HKD","LU2381873111.SGD","IE00BHPRN162.USD","LU0251132253.USD","LU1629891620.HKD","IE000M9KFDE8.USD","JPO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631574784","title":"BRIEF-Insilico Medicine Cayman Topco, Unit Subscribe For Wealth Management Products","url":"https://stock-news.laohu8.com/highlight/detail?id=2631574784","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631574784?lang=en_us&edition=fundamental","pubTime":"2026-04-30 09:56","pubTimestamp":1777514191,"startTime":"0","endTime":"0","summary":"BRIEF-Insilico Medicine Cayman Topco, Unit Subscribe For Wealth Management ProductsApril 30  - Insilico Medicine Cayman TopCo 3696.HK:CO AND UNIT SUBSCRIBES FOR WEALTH MANAGEMENT PRODUCTS ON APRIL 29, 2026SUBSCRIBES TO CMB INTERNATIONAL USD MONEY MARKET FUND FOR USD50 MILLIONUNIT SUBSCRIBES TO USD STANDARD MONEY MARKET VNAV FUND FOR USD50 MILLIONUNIT SUBSCRIBES FOR USD/OFFSHORE RMB DUAL-CURRENCY DEPOSIT FOR USD5 MILLIONFurther company coverage: 3696.HK ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nFWN41C20H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162353834","title":"INSILICO Announces Subscription of Financial Products","url":"https://stock-news.laohu8.com/highlight/detail?id=1162353834","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162353834?lang=en_us&edition=fundamental","pubTime":"2026-04-30 08:16","pubTimestamp":1777508185,"startTime":"0","endTime":"0","summary":"INSILICO (03696) announced that on April 29, 2026, the company and its wholly-owned subsidiary, INSILICO Hong Kong, placed orders to subscribe to the following financial products: (i) the company...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116345551","title":"Insilico Medicine places USD105.00 million in treasury products, cash position rises to USD596.00 million","url":"https://stock-news.laohu8.com/highlight/detail?id=1116345551","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116345551?lang=en_us&edition=fundamental","pubTime":"2026-04-30 08:02","pubTimestamp":1777507374,"startTime":"0","endTime":"0","summary":"Insilico Medicine Cayman TopCo (Insilico) and its wholly owned subsidiary Insilico Medicine Hong Kong Limited disclosed three new treasury allocations on 29 April 2026, involving a total principal of...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631602575","title":"Insilico Medicine Cayman Topco - Co and Unit Subscribes for Wealth Management Products on April 29, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2631602575","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631602575?lang=en_us&edition=fundamental","pubTime":"2026-04-30 08:01","pubTimestamp":1777507308,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nFWN41C20H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1141","03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631575981","title":"Insilico Medicine Cayman Topco - Subscribes to Cmb International USD Money Market Fund for USD50 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2631575981","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631575981?lang=en_us&edition=fundamental","pubTime":"2026-04-30 08:01","pubTimestamp":1777507308,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nFWN41C20H:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["03696","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146903525","title":"Stock Track | Insilico Medicine Soars 5.14% Intraday on China IND Approval for Rentosertib IPF Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=1146903525","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146903525?lang=en_us&edition=fundamental","pubTime":"2026-04-29 14:27","pubTimestamp":1777444041,"startTime":"0","endTime":"0","summary":"Insilico Medicine's stock surged 5.14% during intraday trading on Wednesday, following positive regulatory news regarding its drug development pipeline.The significant price movement comes after the...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631239556","title":"BRIEF-Insilico Medicine Cayman Topco Receives Center For Drug Evaluation's IND Approval For Inhaled Rentosertib","url":"https://stock-news.laohu8.com/highlight/detail?id=2631239556","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631239556?lang=en_us&edition=fundamental","pubTime":"2026-04-29 09:36","pubTimestamp":1777426564,"startTime":"0","endTime":"0","summary":"BRIEF-Insilico Medicine Cayman Topco Receives Center For Drug Evaluation's IND Approval For Inhaled RentosertibApril 29  - Insilico Medicine Cayman TopCo 3696.HK:RECEIVES CENTER FOR DRUG EVALUATION OF NMPA'S IND APPROVAL FOR INHALED RENTOSERTIBFurther company coverage: 3696.HK ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nFWN41B0ZZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631558559","title":"Insilico Medicine Cayman Topco - Receives Center for Drug Evaluation of Nmpa's Ind Approval for Inhaled Rentosertib","url":"https://stock-news.laohu8.com/highlight/detail?id=2631558559","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631558559?lang=en_us&edition=fundamental","pubTime":"2026-04-29 08:02","pubTimestamp":1777420925,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nFWN41B0ZZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["03696","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631855836","title":"Insilico Medicine says China CDE approves IND for Rentosertib inhalation solution","url":"https://stock-news.laohu8.com/highlight/detail?id=2631855836","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631855836?lang=en_us&edition=fundamental","pubTime":"2026-04-29 08:01","pubTimestamp":1777420909,"startTime":"0","endTime":"0","summary":"Insilico Medicine received China IND clearance from NMPA CDE for Rentosertib  inhalation solution in adult idiopathic pulmonary fibrosis.Authorization enables a Phase I study assessing safety, tolerability, and pharmacokinetics, with about 80 subjects planned.Rentosertib previously received US FDA orphan drug designation for idiopathic pulmonary fibrosis in February 2023.China CDE added Rentosertib to its breakthrough therapy designation list in May 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Insilico Medicine Cayman Topco published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 29, 2026, and is solely responsible for the inform","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDL1FbVN5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177716963","title":"INSILICO shifts to fully electronic delivery of corporate communications under HKEX Rule 2.07A","url":"https://stock-news.laohu8.com/highlight/detail?id=1177716963","media":"Bulletin Express","labels":["policyRegulatory","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177716963?lang=en_us&edition=fundamental","pubTime":"2026-04-28 20:43","pubTimestamp":1777380200,"startTime":"0","endTime":"0","summary":"InSilico Medicine Cayman TopCo (INSILICO) announced that, effective 28 April 2026, all future corporate communications will be provided exclusively in electronic form on the company’s website...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193112249","title":"英妙智能2025年报：营收下降与亏损扩大，AI新药研发平台获多方关注，资本结构显著改善","url":"https://stock-news.laohu8.com/highlight/detail?id=1193112249","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193112249?lang=en_us&edition=fundamental","pubTime":"2026-04-28 20:28","pubTimestamp":1777379299,"startTime":"0","endTime":"0","summary":"英妙智能（InSilico Medicine Cayman TopCo，港交所代码：03696）于2025年12月30日成功在香港联交所主板上市，并引入包括礼来（Eli Lilly and...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"英妙智能2025年报：营收下降与亏损扩大，AI新药研发平台获多方关注，资本结构显著改善","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142051984","title":"InSilico Implements Electronic-Only Distribution of Corporate Communications to Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=1142051984","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142051984?lang=en_us&edition=fundamental","pubTime":"2026-04-28 20:26","pubTimestamp":1777379196,"startTime":"0","endTime":"0","summary":"InSilico Medicine Cayman TopCo (英矽智能) has outlined new procedures for delivering corporate communications, moving predominantly to electronic channels in line with Hong Kong Stock Exchange Listing...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192868643","title":"INSILICO Sets 2 June 2026 Virtual AGM; Eyes 10% Buy-Back Mandate and 20% Issuance Capacity","url":"https://stock-news.laohu8.com/highlight/detail?id=1192868643","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192868643?lang=en_us&edition=fundamental","pubTime":"2026-04-28 20:26","pubTimestamp":1777379179,"startTime":"0","endTime":"0","summary":"InSilico Medicine Cayman TopCo (abbreviated as INSILICO) will convene its 2026 annual general meeting (AGM) electronically on 2 June 2026 at 9:00 a.m. via the company’s eVoting Portal. Key agenda...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166909294","title":"INSILICO to Seek Shareholders’ Nod for 10 % Buyback, 20 % Issuance Mandates and Board Re-election at 2 June Virtual AGM","url":"https://stock-news.laohu8.com/highlight/detail?id=1166909294","media":"Bulletin Express","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166909294?lang=en_us&edition=fundamental","pubTime":"2026-04-28 20:25","pubTimestamp":1777379150,"startTime":"0","endTime":"0","summary":"InSilico Medicine Cayman TopCo (INSILICO) has dispatched a circular convening its 2026 annual general meeting (AGM) for 9:00 a.m. on 2 June 2026. The meeting will be conducted exclusively online via...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197863051","title":"InSilico Medicine Schedules 2 June 2026 Virtual AGM; Director Re-elections, 10% Buyback and 20% Issuance Mandates Proposed","url":"https://stock-news.laohu8.com/highlight/detail?id=1197863051","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197863051?lang=en_us&edition=fundamental","pubTime":"2026-04-28 20:23","pubTimestamp":1777379007,"startTime":"0","endTime":"0","summary":"InSilico Medicine Cayman TopCo (INSILICO, stock code 03696) will hold its Annual General Meeting electronically through the eVoting Portal on 2 June 2026 at 9:00 a.m. Hong Kong time. Shareholders may...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630301060","title":"Insilico Medicine Cayman Topco announces annual general meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2630301060","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630301060?lang=en_us&edition=fundamental","pubTime":"2026-04-28 20:18","pubTimestamp":1777378726,"startTime":"0","endTime":"0","summary":"Insilico Medicine Cayman Topco will hold its annual general meeting via electronic meeting through eVoting Portal on June 2, 2026.Shareholders will vote on adoption of audited consolidated financial statements for year ended Dec. 31, 2025.Resolutions include re-election of directors, including executive directors Aleksandrs Zavoronkov and Feng Ren.Meeting will also consider re-appointment of Deloitte Touche Tohmatsu as auditor.Additional proposals cover share buyback mandate of up to 10% of issued shares, share issuance mandate of up to 20%, including extension tied to any repurchases.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Insilico Medicine Cayman Topco published the original content used to generate this news brief via IIS, t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nNDLbrnTjc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177218316","title":"Stock Track | Insilico Medicine Plummets 5.16% Intraday as Profit-Taking Persists Amid Strong Sector Performance","url":"https://stock-news.laohu8.com/highlight/detail?id=1177218316","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177218316?lang=en_us&edition=fundamental","pubTime":"2026-04-28 11:42","pubTimestamp":1777347767,"startTime":"0","endTime":"0","summary":"Insilico Medicine's stock plummeted 5.16% during Tuesday's intraday session, extending a recent decline.The slide is attributed to continued profit-taking following a significant rally driven by...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175762239","title":"Stock Track | Insilico Medicine Plummets 5.65% Intraday as Profit-Taking Follows AI Drug Discovery Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=1175762239","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175762239?lang=en_us&edition=fundamental","pubTime":"2026-04-27 10:57","pubTimestamp":1777258634,"startTime":"0","endTime":"0","summary":"Insilico Medicine's stock experienced a significant intraday decline, plummeting 5.65% during Monday's trading session. This movement follows a period of notable gains for the company.The sharp...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629893818","title":"Insilico Medicine Nominates AI-Developed Brain Cancer Drug Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2629893818","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629893818?lang=en_us&edition=fundamental","pubTime":"2026-04-24 09:54","pubTimestamp":1776995667,"startTime":"0","endTime":"0","summary":"Insilico Medicine  has nominated a new preclinical drug candidate for glioblastoma using its artificial intelligence platform, according to a Friday Hong Kong bourse filing.The candidate, ISM0387, was developed by the company's United Arab Emirates team using its Pharma.AI system and progressed from design to optimization in under 12 months.Insilico said the drug showed improved activity, selectivity, and brain penetration in early studies, with potential as a treatment for brain cancer.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ARTY","BK1141","AIPO","03696","CHAT","AGIX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}]}}